Education
About Us
Working with TipRanks
Follow Us
Michael Amoroso Insider Profile
4 Followers
Michael Amoroso, Director at Abeona Therapeutics, holds 243.39K shares in Precision BioSciences (Ticker: DTIL), holds 217.78K shares in Abeona Therapeutics (Ticker: ABEO).
Profitable Transactions
1 out of 5 Profitable Transactions
Average Return
-101.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Michael Amoroso holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jun 21, 2023 - Jun 21, 2024
Return:+5.10%
The most profitable trade made by Michael Amoroso
Michael Amoroso's Trading History
Abeona Therapeutics
Jan 27, 2026
Director
Uninformative Buy
―
$1.08M
Precision BioSciences
Feb 19, 2026
President & CEO, Director
Uninformative Buy
188.48K
$1.53M
List of latest transactions for each holding click on a transaction to see Michael Amoroso's performance on stock
You May Also Like
Michael Amoroso insider profile FAQ
What is the percentage of profitable transactions made by Michael Amoroso?
The percentage of profitable transactions made by Michael Amoroso is 20%.
What is the average return per transaction made by Michael Amoroso?
The average return per transaction made by Michael Amoroso is -101.90%.
What stocks does Michael Amoroso hold?
Michael Amoroso holds: ABEO, DTIL stocks.
What was Michael Amoroso’s latest transaction?
Michael Amoroso latest transaction was an Uninformative Buy of $188.48K.
What was Michael Amoroso's most profitable transaction?
Michael Amoroso’s most profitable transaction was an Informative Sell of ABEO stock on June 21, 2023. The return on the trade was 5.10%.
What is Michael Amoroso's role in Abeona Therapeutics?
Michael Amoroso's role in Abeona Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.